X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs PFIZER - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD PFIZER MERCK LTD/
PFIZER
 
P/E (TTM) x 26.9 24.5 109.7% View Chart
P/BV x 3.0 3.9 77.2% View Chart
Dividend Yield % 0.9 0.8 113.0%  

Financials

 MERCK LTD   PFIZER
EQUITY SHARE DATA
    MERCK LTD
Dec-16
PFIZER
Mar-16
MERCK LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,0602,724 38.9%   
Low Rs6231,611 38.7%   
Sales per share (Unadj.) Rs632.4440.9 143.4%  
Earnings per share (Unadj.) Rs45.748.7 93.9%  
Cash flow per share (Unadj.) Rs62.375.8 82.2%  
Dividends per share (Unadj.) Rs11.0015.00 73.3%  
Dividend yield (eoy) %1.30.7 188.9%  
Book value per share (Unadj.) Rs388.8462.9 84.0%  
Shares outstanding (eoy) m16.6045.75 36.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.34.9 27.1%   
Avg P/E ratio x18.444.5 41.4%  
P/CF ratio (eoy) x13.528.6 47.2%  
Price / Book Value ratio x2.24.7 46.2%  
Dividend payout %24.130.8 78.1%   
Avg Mkt Cap Rs m13,96999,163 14.1%   
No. of employees `0001.62.9 54.8%   
Total wages/salary Rs m1,4872,758 53.9%   
Avg. sales/employee Rs Th6,631.96,981.7 95.0%   
Avg. wages/employee Rs Th939.2954.5 98.4%   
Avg. net profit/employee Rs Th479.4771.1 62.2%   
INCOME DATA
Net Sales Rs m10,49820,170 52.0%  
Other income Rs m242857 28.3%   
Total revenues Rs m10,74121,028 51.1%   
Gross profit Rs m1,1354,310 26.3%  
Depreciation Rs m2761,239 22.2%   
Interest Rs m05 0.0%   
Profit before tax Rs m1,1023,923 28.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m3431,794 19.1%   
Profit after tax Rs m7592,228 34.1%  
Gross profit margin %10.821.4 50.6%  
Effective tax rate %31.145.7 68.1%   
Net profit margin %7.211.0 65.4%  
BALANCE SHEET DATA
Current assets Rs m6,41016,299 39.3%   
Current liabilities Rs m8,8287,594 116.3%   
Net working cap to sales %-23.043.2 -53.4%  
Current ratio x0.72.1 33.8%  
Inventory Days Days5865 88.4%  
Debtors Days Days3826 149.1%  
Net fixed assets Rs m1,4068,622 16.3%   
Share capital Rs m166458 36.3%   
"Free" reserves Rs m6,28620,722 30.3%   
Net worth Rs m6,45521,180 30.5%   
Long term debt Rs m025 0.0%   
Total assets Rs m8,82829,137 30.3%  
Interest coverage xNM755.5-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.7 171.8%   
Return on assets %8.67.7 112.2%  
Return on equity %11.810.5 111.8%  
Return on capital %17.119.0 89.9%  
Exports to sales %8.30.1 13,919.7%   
Imports to sales %21.017.5 120.4%   
Exports (fob) Rs m86912 7,245.0%   
Imports (cif) Rs m2,2093,526 62.7%   
Fx inflow Rs m95952 1,856.3%   
Fx outflow Rs m2,612140 1,866.0%   
Net fx Rs m-1,653-88 1,871.6%   
CASH FLOW
From Operations Rs m1,0703,436 31.1%  
From Investments Rs m-750-6,991 10.7%  
From Financial Activity Rs m-150-619 24.2%  
Net Cashflow Rs m171-4,174 -4.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 63.9 81.1%  
Indian inst/Mut Fund % 18.2 7.5 242.7%  
FIIs % 1.0 4.9 20.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 23.7 122.8%  
Shareholders   28,591 85,207 33.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 23, 2017 09:54 AM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - TTK HEALTHCARE COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS